SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Activity
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings

69 hedge funds and large institutions have $154M invested in Syros Pharmaceuticals, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 17 closing their positions.

Holders
69
Holders Change
+1
Holders Change %
+1.47%
% of All Funds
1.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
18
Increased
25
Reduced
14
Closed
17
Calls
$28K
Puts
$267K
Net Calls
-$239K
Net Calls Change
-$239K

Top Buyers

1
AIM
1
ARK Investment Management
Florida
$8.12M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$3.2M
3
CS
3
Candriam SCA
Luxembourg
$2.04M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$5.67M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$285K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
EC
2
EcoR1 Capital
California
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
NI
5
Numeric Investors
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$38.4M 3,944,465 +5,435 +0.1%
FP
2
Flagship Pioneering
Massachusetts
$31.2M 3,204,437 – –
DM
3
Deerfield Management
New York
$12.3M 1,268,945 – –
Wellington Management Group
4
Wellington Management Group
Massachusetts
$9.7M 996,779 +820 +0.1%
AIM
5
ARK Investment Management
Florida
$8.12M 834,757 +700,058 +520%
RG
6
Redmile Group
California
$6.2M 637,232 -4,187 -0.7%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.67M 582,499 +32,515 +6%
BBA
8
Baker Bros. Advisors
New York
$5.59M 574,835 – –
BlackRock
9
BlackRock
New York
$5.59M 574,946 +5,150 +0.9%
AC
10
Aisling Capital
New York
$4.95M 508,565 – –
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$3.2M 328,798 +202,268 +160%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$3.02M 309,956 +1,296 +0.4%
CAM
13
Cormorant Asset Management
Massachusetts
$2.88M 296,296 – –
CC
14
Casdin Capital
New York
$2.67M 274,074 +17,859 +7%
CS
15
Candriam SCA
Luxembourg
$2.04M 210,000 +90,000 +75%
State Street
16
State Street
Massachusetts
$1.86M 190,643 -1,793 -0.9%
EAM
17
Eventide Asset Management
Massachusetts
$1.46M 150,000 – –
Northern Trust
18
Northern Trust
Illinois
$1.31M 134,163 -2,101 -2%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$931K 95,755 +864 +0.9%
OM
20
Opaleye Management
Massachusetts
$720K 74,074 -42,500 -36%
AIC
21
AWM Investment Company
New York
$632K 65,000 -60,000 -48%
PP
22
PDT Partners
New York
$601K 61,805 +18,439 +43%
Charles Schwab
23
Charles Schwab
California
$423K 43,425 +1,716 +4%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$343K 35,219 -110 -0.3%
Russell Investments Group
25
Russell Investments Group
United Kingdom
$330K 33,418 +24,393 +270%
1
2 3 4